Roche and Illumina remain at loggerheads
Roche and Illumina remained at loggerheads on Tuesday, as the $6.7bn battle for control of the US gene sequencing group entered a potentially decisive week.
Roche announced Wednesday it had launched a takeover bid for Illumina, a US company that specialises in life sciences.